These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33038591)

  • 1. Two Different Composite Markers Predict Severity and Threshold Dose in Peanut Allergy.
    Cottel N; Saf S; Bourgoin-Heck M; Lambert N; Amat F; Poncet P; Senechal H; Couderc R; Just J; Chantran Y
    J Allergy Clin Immunol Pract; 2021 Jan; 9(1):275-282.e1. PubMed ID: 33038591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of severity and threshold of allergic reactions during oral peanut challenges.
    Santos AF; Du Toit G; O'Rourke C; Becares N; Couto-Francisco N; Radulovic S; Khaleva E; Basting M; Harris KM; Larson D; Sayre P; Plaut M; Roberts G; Bahnson HT; Lack G
    J Allergy Clin Immunol; 2020 Aug; 146(2):344-355. PubMed ID: 32311390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of Ara h 2-sIgE and basophil activation test could be an alternative to oral food challenge in cases of suspected peanut allergy.
    Carrette M; Couderc L; Bubenheim M; Vidal A; Youssouf A; Boyer O; Marguet C; Martinet J
    Pediatr Allergy Immunol; 2023 Aug; 34(8):e14007. PubMed ID: 37622254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Indirect Basophil Activation Test Is a Safe, Reliable, and Accessible Tool to Diagnose a Peanut Allergy in Children.
    Ruinemans-Koerts J; Brouwer ML; Schmidt-Hieltjes Y; Stevens P; Merkus PJFM; Doggen CMJ; Savelkoul HFJ; van Setten PA
    J Allergy Clin Immunol Pract; 2022 May; 10(5):1305-1311.e3. PubMed ID: 35074603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut.
    Santos AF; Du Toit G; Douiri A; Radulovic S; Stephens A; Turcanu V; Lack G
    J Allergy Clin Immunol; 2015 Jan; 135(1):179-86. PubMed ID: 25567046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified oral food challenge used with sensitization biomarkers provides more real-life clinical thresholds for peanut allergy.
    Blumchen K; Beder A; Beschorner J; Ahrens F; Gruebl A; Hamelmann E; Hansen G; Heinzmann A; Nemat K; Niggemann B; Wahn U; Beyer K
    J Allergy Clin Immunol; 2014 Aug; 134(2):390-8. PubMed ID: 24831438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting reactivity threshold in children with anaphylaxis to peanut.
    Reier-Nilsen T; Michelsen MM; Lødrup Carlsen KC; Carlsen KH; Mowinckel P; Nygaard UC; Namork E; Borres MP; Håland G
    Clin Exp Allergy; 2018 Apr; 48(4):415-423. PubMed ID: 29284183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peanut Allergen Threshold Study (PATS): Novel single-dose oral food challenge study to validate eliciting doses in children with peanut allergy.
    Hourihane JO; Allen KJ; Shreffler WG; Dunngalvin G; Nordlee JA; Zurzolo GA; Dunngalvin A; Gurrin LC; Baumert JL; Taylor SL
    J Allergy Clin Immunol; 2017 May; 139(5):1583-1590. PubMed ID: 28238744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basophil allergen threshold sensitivity, CD-sens, IgE-sensitization and DBPCFC in peanut-sensitized children.
    Glaumann S; Nopp A; Johansson SG; Rudengren M; Borres MP; Nilsson C
    Allergy; 2012 Feb; 67(2):242-7. PubMed ID: 22126416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy: The Markers of Nut Allergy Study.
    Duan L; Celik A; Hoang JA; Schmidthaler K; So D; Yin X; Ditlof CM; Ponce M; Upton JEM; Lee JS; Hung L; Breiteneder H; Palladino C; Atkinson AR; Kim VHD; Berenjy A; Asper M; Hummel D; Wong S; Alexanian-Farr M; Magder A; Chinthrajah SR; Mukai K; Tsai M; Nadeau K; Galli SJ; Ramani AK; Szepfalusi Z; Eiwegger T
    Allergy; 2021 Jun; 76(6):1800-1812. PubMed ID: 33300157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early decrease in basophil sensitivity to Ara h 2 precedes sustained unresponsiveness after peanut oral immunotherapy.
    Patil SU; Steinbrecher J; Calatroni A; Smith N; Ma A; Ruiter B; Virkud Y; Schneider M; Shreffler WG
    J Allergy Clin Immunol; 2019 Nov; 144(5):1310-1319.e4. PubMed ID: 31377342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progenitor cell-derived basophils: A novel barcoded passive degranulation assay in allergic diseases.
    Wu J; Bahri R; Tsoumani M; Semic-Jusufagic A; Murray CS; Custovic A; Guibas GV; Bennett M; Wang R; Gauvreau G; Cusack R; Mills C; Bulfone-Paus S; Simpson A
    Clin Exp Allergy; 2023 Apr; 53(4):405-416. PubMed ID: 36385515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relevance of basophil allergen sensitivity testing to distinguish between severe and mild peanut-allergic children.
    Homšak M; Silar M; Berce V; Tomazin M; Skerbinjek-Kavalar M; Celesnik N; Košnik M; Korošec P
    Int Arch Allergy Immunol; 2013; 162(4):310-7. PubMed ID: 24193167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individually dosed omalizumab: an effective treatment for severe peanut allergy.
    Brandström J; Vetander M; Lilja G; Johansson SG; Sundqvist AC; Kalm F; Nilsson C; Nopp A
    Clin Exp Allergy; 2017 Apr; 47(4):540-550. PubMed ID: 27883239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basophil Activation Test Reduces Oral Food Challenges to Nuts and Sesame.
    Santos AF; Bergmann M; Brough HA; Couto-Francisco N; Kwok M; Panetta V; Haddad D; Lack G; Eigenmann P; Caubet JC
    J Allergy Clin Immunol Pract; 2021 May; 9(5):2016-2027.e6. PubMed ID: 33385591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining avidin with CD63 improves basophil activation test accuracy in classifying peanut allergy.
    Castaño N; Chua K; Kaushik A; Kim S; Cordts SC; Nafarzadegan CD; Hofmann GH; Seastedt H; Schuetz JP; Dunham D; Parsons ES; Tsai M; Cao S; Desai M; Sindher SB; Chinthrajah RS; Galli SJ; Nadeau KC; Tang SKY
    Allergy; 2024 Feb; 79(2):445-455. PubMed ID: 37916710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study on basophil activation test, histamine release assay, and passive sensitization histamine release assay in the diagnosis of peanut allergy.
    Larsen LF; Juel-Berg N; Hansen KS; Clare Mills EN; van Ree R; Poulsen LK; Jensen BM
    Allergy; 2018 Jan; 73(1):137-144. PubMed ID: 28686296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fraction of exhaled nitric oxide improves prediction of clinical allergic reaction to peanut challenge in children.
    Preece K; Bhatia R; Belcher J; Patchett K; McElduff P; Collison A; Mattes J
    Clin Exp Allergy; 2014 Mar; 44(3):371-80. PubMed ID: 24345088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender, prick test size and rAra h 2 sIgE level may predict the eliciting dose in patients with peanut allergy: Evidence from the Mirabel survey.
    Elegbede CF; Papadopoulos A; Just J; Moneret-Vautrin DA; Deschildre A; Crépet A
    Clin Exp Allergy; 2019 May; 49(5):677-689. PubMed ID: 30689235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ara h 2 and Ara 6 are the best predictors of severe peanut allergy: a double-blind placebo-controlled study.
    Kukkonen AK; Pelkonen AS; Mäkinen-Kiljunen S; Voutilainen H; Mäkelä MJ
    Allergy; 2015 Oct; 70(10):1239-45. PubMed ID: 26095653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.